Drug Type Monoclonal antibody |
Synonyms HUB-F5 |
Target |
Action modulators |
Mechanism CD4 modulators(T-cell surface antigen CD4 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Rheumatoid Arthritis | Clinical | Russia | - |






